Overview: Allergy Mesquite TestIntroduction: The Allergy Mesquite Test detects IgE antibodies to mesquite pollen, which may cause sneezing, itchy eyes, or asthma during pollen season. Aligned with 2023 AAAAI guidelines, it uses an immunoassay for high sensitivity, aiding in confirming pollen allergies. This test is critical for guiding avoidance strategies or immunotherapy, preventing allergic reactions, and improving outcomes in allergology, particularly in arid regions.
Other Names: Allergy Mesquite Assay, Mesquite IgE Test.
FDA Status: Laboratory-developed test (LDT) meeting allergology standards for diagnostic accuracy.
Historical Milestone: Pollen allergy testing began in the 1960s with skin tests. Specific IgE immunoassays emerged in the 1980s, and by the 2000s, advanced assays improved specificity for tree pollens like mesquite.
Purpose: Diagnoses mesquite pollen allergies, guides avoidance or immunotherapy, and monitors allergic responses in patients with respiratory or ocular symptoms.
Test Parameters: 1. Mesquite IgE
Pretest Condition: No fasting required. Collect serum or saliva at any time, preferably during pollen season or symptom onset. Report symptoms like sneezing, itchy eyes, or asthma, and list medications like antihistamines.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document allergic symptoms, pollen exposure history, or family history of allergies or asthma. Include current medications, especially antihistamines or corticosteroids.
Consent: Written consent required, explaining the tests purpose, diagnostic implications, and potential need for avoidance or immunotherapy.
Procedural Considerations: Uses an immunoassay to measure mesquite-specific IgE. Results are available in 1-2 days, supporting rapid diagnosis.
Factors Affecting Result Accuracy: Antihistamines may suppress IgE levels, causing false negatives. Hemolysis or improper storage can degrade samples. Testing outside pollen season may reduce sensitivity.
Clinical Significance: Elevated mesquite-specific IgE confirms allergy, prompting avoidance or immunotherapy. Normal levels may require skin testing for confirmation.
Specialist Consultation: Consult an allergist for result interpretation. Immunotherapy specialists are advised for severe cases.
Additional Supporting Tests: Skin prick test, total IgE, or tree pollen panel to confirm mesquite allergy or identify cross-reactive pollens.
Test Limitations: False negatives may occur with antihistamine use or low pollen exposure. Cross-reactivity with other tree pollens requires clinical correlation.
References: AAAAI Allergy Guidelines, 2023; Annals of Allergy, Asthma and Immunology, Weber RW, 2022.
